[Skip to Content]
[Skip to Content Landing]
September 19, 2001

Skin Manifestations of Fabry Disease

Author Affiliations

Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001

JAMA. 2001;286(11):1315. doi:10.1001/jama.286.11.1311

To the Editor: Dr Schiffmann and colleagues1 reported that intravenous administration of α-galactosidase A has a number of beneficial effects in patients with Fabry disease. However, it would be of interest to know the extent of the patients' cutaneous lesions2,3 and whether they were affected by treatment with α-galactosidase A.

First Page Preview View Large
First page PDF preview
First page PDF preview